Atlas Trials

Observational Study to Evaluate Safety of Idarucizumab in Pediatric Patients

Clinical trial NCT02798107 · WITHDRAWN

Trial details

NCT number
NCT02798107
Sponsor
Boehringer Ingelheim
Status
WITHDRAWN
Study type
OBSERVATIONAL
Hemorrhage
Start date
2019-05-20
Primary completion
2019-05-23
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.